207 related articles for article (PubMed ID: 10809231)
21. GnRHs and GnRH receptors.
Millar RP
Anim Reprod Sci; 2005 Aug; 88(1-2):5-28. PubMed ID: 16140177
[TBL] [Abstract][Full Text] [Related]
22. A chicken gonadotropin-releasing hormone receptor that confers agonist activity to mammalian antagonists. Identification of D-Lys(6) in the ligand and extracellular loop two of the receptor as determinants.
Sun YM; Flanagan CA; Illing N; Ott TR; Sellar R; Fromme BJ; Hapgood J; Sharp P; Sealfon SC; Millar RP
J Biol Chem; 2001 Mar; 276(11):7754-61. PubMed ID: 11112780
[TBL] [Abstract][Full Text] [Related]
23. Chimaeric gonadotropin-releasing hormone (GnRH) peptides with improved affinity for the catfish (Clarias gariepinus) GnRH receptor.
Blomenröhr M; ter Laak T; Kühne R; Beyermann M; Hund E; Bogerd J; Leurs R
Biochem J; 2002 Feb; 361(Pt 3):515-23. PubMed ID: 11802781
[TBL] [Abstract][Full Text] [Related]
24. Differences in structure-function relations between nonmammalian and mammalian gonadotropin-releasing hormone receptors.
Blomenröhr M; Bogerd J; Leurs R; Schulz RW; Tensen CP; Zandbergen MA; Goos HJ
Biochem Biophys Res Commun; 1997 Sep; 238(2):517-22. PubMed ID: 9299543
[TBL] [Abstract][Full Text] [Related]
25. Mapping the binding site of six nonpeptide antagonists to the human V2-renal vasopressin receptor.
Macion-Dazard R; Callahan N; Xu Z; Wu N; Thibonnier M; Shoham M
J Pharmacol Exp Ther; 2006 Feb; 316(2):564-71. PubMed ID: 16234409
[TBL] [Abstract][Full Text] [Related]
26. Two mutations in extracellular loop 2 of the human GnRH receptor convert an antagonist to an agonist.
Ott TR; Troskie BE; Roeske RW; Illing N; Flanagan CA; Millar RP
Mol Endocrinol; 2002 May; 16(5):1079-88. PubMed ID: 11981042
[TBL] [Abstract][Full Text] [Related]
27. Combined modification of intracellular and extracellular loci on human gonadotropin-releasing hormone receptor provides a mechanism for enhanced expression.
Maya-Núñez G; Janovick JA; Conn PM
Endocrine; 2000 Dec; 13(3):401-7. PubMed ID: 11216654
[TBL] [Abstract][Full Text] [Related]
28. An intramolecular disulfide bond between conserved extracellular cysteines in the gonadotropin-releasing hormone receptor is essential for binding and activation.
Cook JV; Eidne KA
Endocrinology; 1997 Jul; 138(7):2800-6. PubMed ID: 9202220
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological characterization of a novel nonpeptide antagonist of the human gonadotropin-releasing hormone receptor, NBI-42902.
Struthers RS; Xie Q; Sullivan SK; Reinhart GJ; Kohout TA; Zhu YF; Chen C; Liu XJ; Ling N; Yang W; Maki RA; Bonneville AK; Chen TK; Bozigian HP
Endocrinology; 2007 Feb; 148(2):857-67. PubMed ID: 17095587
[TBL] [Abstract][Full Text] [Related]
30. Expression, structure, function, and evolution of gonadotropin-releasing hormone (GnRH) receptors GnRH-R1SHS and GnRH-R2PEY in the teleost, Astatotilapia burtoni.
Flanagan CA; Chen CC; Coetsee M; Mamputha S; Whitlock KE; Bredenkamp N; Grosenick L; Fernald RD; Illing N
Endocrinology; 2007 Oct; 148(10):5060-71. PubMed ID: 17595228
[TBL] [Abstract][Full Text] [Related]
31. Mutations remote from the human gonadotropin-releasing hormone (GnRH) receptor-binding sites specifically increase binding affinity for GnRH II but not GnRH I: evidence for ligand-selective, receptor-active conformations.
Lu ZL; Gallagher R; Sellar R; Coetsee M; Millar RP
J Biol Chem; 2005 Aug; 280(33):29796-803. PubMed ID: 15967801
[TBL] [Abstract][Full Text] [Related]
32. Histidine(7.36(305)) in the conserved peptide receptor activation domain of the gonadotropin releasing hormone receptor couples peptide binding and receptor activation.
Mayevu NM; Choe H; Abagyan R; Seong JY; Millar RP; Katz AA; Flanagan CA
Mol Cell Endocrinol; 2015 Feb; 402():95-106. PubMed ID: 25583361
[TBL] [Abstract][Full Text] [Related]
33. Evolution of constrained gonadotropin-releasing hormone ligand conformation and receptor selectivity.
Barran PE; Roeske RW; Pawson AJ; Sellar R; Bowers MT; Morgan K; Lu ZL; Tsuda M; Kusakabe T; Millar RP
J Biol Chem; 2005 Nov; 280(46):38569-75. PubMed ID: 16157590
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of growth and proliferation of EcRG293 cell line expressing high-affinity gonadotropin-releasing hormone (GnRH) receptor under the control of an inducible promoter by GnRH agonist (D-Lys6)GnRH and antagonist (Antide).
Kakar SS
Cancer Res; 1998 Oct; 58(20):4558-60. PubMed ID: 9788600
[TBL] [Abstract][Full Text] [Related]
35. Position of Pro and Ser near Glu7.32 in the extracellular loop 3 of mammalian and nonmammalian gonadotropin-releasing hormone (GnRH) receptors is a critical determinant for differential ligand selectivity for mammalian GnRH and chicken GnRH-II.
Wang C; Yun O; Maiti K; Oh DY; Kim KK; Chae CH; Lee CJ; Seong JY; Kwon HB
Mol Endocrinol; 2004 Jan; 18(1):105-16. PubMed ID: 14525953
[TBL] [Abstract][Full Text] [Related]
36. GnRH-II antagonists induce apoptosis in human endometrial, ovarian, and breast cancer cells via activation of stress-induced MAPKs p38 and JNK and proapoptotic protein Bax.
Fister S; Günthert AR; Aicher B; Paulini KW; Emons G; Gründker C
Cancer Res; 2009 Aug; 69(16):6473-81. PubMed ID: 19638591
[TBL] [Abstract][Full Text] [Related]
37. The third intracellular loop of the rat gonadotropin-releasing hormone receptor couples the receptor to Gs- and G(q/11)-mediated signal transduction pathways: evidence from loop fragment transfection in GGH3 cells.
Ulloa-Aguirre A; Stanislaus D; Arora V; Väänänen J; Brothers S; Janovick JA; Conn PM
Endocrinology; 1998 May; 139(5):2472-8. PubMed ID: 9564860
[TBL] [Abstract][Full Text] [Related]
38. Biological characterization of a novel, orally active small molecule gonadotropin-releasing hormone (GnRH) antagonist using castrated and intact rats.
Anderes KL; Luthin DR; Castillo R; Kraynov EA; Castro M; Nared-Hood K; Gregory ML; Pathak VP; Christie LC; Paderes G; Vazir H; Ye Q; Anderson MB; May JM
J Pharmacol Exp Ther; 2003 May; 305(2):688-95. PubMed ID: 12606616
[TBL] [Abstract][Full Text] [Related]
39. Antagonist and agonist binding models of the human gonadotropin-releasing hormone receptor.
Söderhäll JA; Polymeropoulos EE; Paulini K; Günther E; Kühne R
Biochem Biophys Res Commun; 2005 Jul; 333(2):568-82. PubMed ID: 15950933
[TBL] [Abstract][Full Text] [Related]
40. Hexapeptide and cyclic pentapeptide endothelin antagonists directly activate pituitary gonadotropin-releasing hormone receptors.
Yahalom D; Koch Y; Ben-Aroya N; Fridkin M
Mol Pharmacol; 2000 Apr; 57(4):718-24. PubMed ID: 10727517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
